RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe ...

But low uptake this season is, so far, in line with expectations. Fewer COVID-19 and RSV (respiratory syncytial virus) vaccines have been administered this year than were administered around the ...

Rates of SUID per 100,000 live births rose by 10% from 2019 to 2021. A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of respiratory syncytial virus ...

GSK’s RSV vaccine is the only RSV vaccine with efficacy and safety data available through three full seasons, including in people at increased risk Safety and reactogenicity data are consistent ...

Their report, published in Nature Communications, includes high-resolution images detailing the structure of two RSV proteins, RSV M and RSV F, that are crucial to interactions between the virus ...

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV) receiving care through the emergency department. Respiratory ...

Oct 8 (Reuters) - GSK (GSK.L), opens new tab said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in its third season after patients ...

HOUSTON, Texas (KTRK) -- Respiratory syncytial virus, or RSV, is the leading cause of hospitalizations for infants. It's a major risk for older children, too, and can be dangerous, even life ...

Their report, published in Nature Communications, includes high-resolution images detailing the structure of two RSV proteins, RSV M and RSV F, that are crucial to interactions between the virus and ...

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that ...